tiprankstipranks
Trending News
More News >
Care Twentyone Corporation (JP:2373)
:2373
Japanese Market

Care Twentyone Corporation (2373) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2373

Care Twentyone Corporation

(2373)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 4o)
Rating:60Neutral
Price Target:
¥438.00
▲(5.04% Upside)
The overall stock score for Care Twentyone Corporation is driven primarily by its financial performance and valuation. While the company shows steady revenue growth, challenges with profitability and high leverage are notable concerns. The technical analysis indicates a bearish trend, which negatively impacts the score. However, the reasonable P/E ratio and attractive dividend yield provide some positive offset.
Positive Factors
Revenue Growth
Steady revenue growth indicates strong demand for services and effective market penetration, supporting long-term business sustainability.
Cash Flow Improvement
Improved cash flow enhances financial flexibility, allowing for reinvestment in growth opportunities and debt reduction, strengthening the balance sheet.
Industry Position
A strong position in the growing eldercare market provides a competitive advantage and potential for sustained revenue streams as the population ages.
Negative Factors
High Leverage
Significant leverage can lead to financial strain, limiting the company's ability to invest in growth and increasing vulnerability to economic downturns.
Profitability Challenges
Low profitability margins indicate challenges in cost management and pricing power, which could hinder long-term earnings growth and shareholder returns.
Volatile Free Cash Flow
Volatile free cash flow can impact the company's ability to consistently fund operations and growth initiatives, posing a risk to financial stability.

Care Twentyone Corporation (2373) vs. iShares MSCI Japan ETF (EWJ)

Care Twentyone Corporation Business Overview & Revenue Model

Company DescriptionCare Twentyone Corporation (2373) is a prominent player in the healthcare sector, specializing in providing comprehensive nursing care and wellness services. The company operates primarily in the eldercare market, offering a range of services that include residential care facilities, home healthcare, and rehabilitation services. With a focus on enhancing the quality of life for seniors, Care Twentyone Corporation integrates modern medical practices with compassionate care, ensuring that their clients receive personalized support tailored to their individual needs.
How the Company Makes MoneyCare Twentyone Corporation generates revenue through multiple streams, primarily from its residential care facilities and home healthcare services. The company charges clients for accommodations, medical care, and support services, which can be billed on a monthly or per-service basis. Additionally, Care Twentyone may partner with insurance providers and government programs to facilitate coverage for their services, enhancing accessibility for clients. Significant partnerships with healthcare networks and local agencies also contribute to their earnings by providing referrals and expanding their service reach. Furthermore, the company may engage in wellness programs and rehabilitation services that are billed separately, adding to its overall revenue.

Care Twentyone Corporation Financial Statement Overview

Summary
Care Twentyone Corporation demonstrates steady revenue growth and operational stability, but faces challenges with profitability and high leverage. The cash flow position is improving, yet historical volatility in free cash flow growth indicates potential risks. Overall, the company needs to focus on enhancing profitability and managing leverage to strengthen its financial position.
Income Statement
Care Twentyone Corporation has shown consistent revenue growth over the years, with a 2.33% increase in the latest period. However, the net profit margin remains low at 0.80%, indicating challenges in converting revenue into profit. The gross profit margin is stable at 22.05%, but the EBIT and EBITDA margins are relatively low, suggesting potential inefficiencies in operations.
Balance Sheet
The company has a high debt-to-equity ratio of 4.19, indicating significant leverage, which could pose financial risks. Return on equity is modest at 8.69%, showing moderate efficiency in generating returns from shareholders' equity. The equity ratio is not explicitly calculated, but the high leverage suggests a lower proportion of equity in the capital structure.
Cash Flow
Operating cash flow has improved, with a strong operating cash flow to net income ratio of 5.65. Free cash flow is positive, but the free cash flow to net income ratio is slightly below 1, indicating that not all net income is translating into free cash flow. The company has shown improvement in free cash flow growth, but historical fluctuations suggest potential volatility.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue47.71B48.16B45.40B41.10B38.40B36.36B
Gross Profit10.72B10.62B9.66B9.01B9.27B8.73B
EBITDA2.43B2.54B2.20B2.33B3.12B3.53B
Net Income604.99M384.18M278.42M6.16M630.49M937.08M
Balance Sheet
Total Assets31.33B31.03B31.67B31.82B36.38B37.60B
Cash, Cash Equivalents and Short-Term Investments3.84B4.17B3.08B2.61B1.88B2.83B
Total Debt19.41B18.55B19.49B18.34B22.51B22.96B
Total Liabilities26.98B26.54B26.94B26.30B29.90B30.83B
Stockholders Equity4.28B4.42B4.71B5.50B6.46B6.77B
Cash Flow
Free Cash Flow0.002.02B-502.44M479.68M184.12M1.42B
Operating Cash Flow0.002.17B709.85M2.14B1.11B2.61B
Investing Cash Flow0.00139.26M-1.02B-2.60B-1.39B-1.38B
Financing Cash Flow0.00-1.20B782.01M1.20B-679.93M-1.33B

Care Twentyone Corporation Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price417.00
Price Trends
50DMA
441.84
Negative
100DMA
447.10
Negative
200DMA
420.99
Positive
Market Momentum
MACD
-5.12
Negative
RSI
44.74
Neutral
STOCH
43.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2373, the sentiment is Neutral. The current price of 417 is below the 20-day moving average (MA) of 421.95, below the 50-day MA of 441.84, and below the 200-day MA of 420.99, indicating a neutral trend. The MACD of -5.12 indicates Negative momentum. The RSI at 44.74 is Neutral, neither overbought nor oversold. The STOCH value of 43.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:2373.

Care Twentyone Corporation Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥3.06B11.652.56%-3.06%-38.56%
75
Outperform
¥5.04B11.3716.12%107.25%
72
Outperform
¥2.42B5.684.76%1.84%92.34%
68
Neutral
¥3.28B9.752.64%4.69%103.59%
60
Neutral
¥5.71B14.904.07%6.08%38.00%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
¥13.38B-4.5910.09%-340.83%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2373
Care Twentyone Corporation
424.00
90.58
27.17%
JP:2425
Care Service Co., Ltd.
806.00
-56.93
-6.60%
JP:2435
Cedar. Co.,Ltd
216.00
-1.07
-0.49%
JP:7091
Living Platform Ltd.
1,126.00
201.00
21.73%
JP:7129
Miahelsa Holdings Corporation
1,172.00
110.71
10.43%
JP:9229
SUNWELS Co.,Ltd.
380.00
-218.45
-36.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 19, 2025